Track the Whitehawk Therapeutics, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). The latest transaction was reported on 17 April 2026 (Cession). Among the most active insiders: Lennon David James. Every trade is accessible without an account.
17
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€2m
11 ops.
Sell Volume
38Σ signal
Buys ·€2m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Whitehawk Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for autoimmune diseases. It employs innovative approaches to target the underlying mechanisms of these conditions.